Principia Wealth Advisory’s GSK GSK Stock Holding History

Principia Wealth Advisory’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.71K	Sell	147 -2	-1%	-$106	﹤0.01%	285
2026 Q1	$8.22K	Buy	149 +40	+37%	+$2.17K	﹤0.01%	230
2025 Q4	$5.34K	Hold	109	–	–	﹤0.01%	264
2025 Q3	$4.7K	Buy	109 +72	+195%	+$2.81K	﹤0.01%	278
2025 Q2	$1.42K	Buy	+37	New	+$1.41K	﹤0.01%	474

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Principia Wealth Advisory's GSK Position: Q2 2026 in Review

Principia Wealth Advisory reduced its GSK (GSK) stake by 1.3% in Q2 2026, selling an estimated $106 and leaving 147 shares worth $7.71K. The position accounts for ﹤0.01% of the portfolio, ranked #285.

Principia Wealth Advisory first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.22K in Q1 2026. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Principia Wealth Advisory held 147 shares of GSK worth $7.71K as of Q2 2026.
Principia Wealth Advisory sold 2 GSK shares in Q2 2026, an estimated $106.
GSK made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #285 holding.
Principia Wealth Advisory first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
Principia Wealth Advisory's GSK position peaked at $8.22K in Q1 2026.
1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.